Hospital medication adherence scale development in cardiovascular disorders
| dc.rights.license | open | en_US |
| hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
| dc.contributor.author | MARTIN-LATRY, Karin
IDREF: 070296685 | |
| dc.contributor.author | LATRY, P | |
| dc.contributor.author | PUCHEU, Y | |
| hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
| dc.contributor.author | COUFFINHAL, Thierry | |
| dc.date.accessioned | 2021-02-02T15:55:12Z | |
| dc.date.available | 2021-02-02T15:55:12Z | |
| dc.date.issued | 2020-12-10 | |
| dc.identifier.issn | 0003-4509 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/26101 | |
| dc.description.abstractEn | The consequences of non-adherence to prescribed cardiovascular drugs can be serious, with cardiovascular complications having been reported in both secondary and primary prevention. The objective of this study was to develop a new scale to assess medication adherence in patients with cardiovascular diseases during their hospitalization. A cohort of 219 high risk cardiovascular patients was evaluated for this study. Data on reasons for non-adherence were collected using the newly developed Medication Adherence Scale in Cardiovascular disorders (Mascard) and compared with physician assessment during medical consultations and the control of their cardiovascular risk factors. The Mascard consists of 5 items has good psychometric properties and validity and correlated with physician assessment and control of cardiovascular risk factors. This rapid and easy to use scale may be useful for health care practitioners in their assessment of medication adherence in inpatients with cardiovascular disorders. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Medication | |
| dc.subject.en | adherence | |
| dc.subject.en | Cardiovascular drugs | |
| dc.subject.en | Scale | |
| dc.title.en | Hospital medication adherence scale development in cardiovascular disorders | |
| dc.title.alternative | Ann Pharm Fr | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.pharma.2020.11.008 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Médecine humaine et pathologie | |
| dc.identifier.pubmed | 33309605 | en_US |
| bordeaux.journal | Annales Pharmaceutiques Françaises | en_US |
| bordeaux.hal.laboratories | Biologie des maladies cardiovasculaires - U1034 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | oui | en_US |
| bordeaux.import.source | pubmed | |
| hal.identifier | hal-03194486 | |
| hal.version | 1 | |
| hal.date.transferred | 2021-04-09T13:32:36Z | |
| hal.export | true | |
| workflow.import.source | pubmed | |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Annales%20Pharmaceutiques%20Fran%C3%A7aises&rft.date=2020-12-10&rft.eissn=0003-4509&rft.issn=0003-4509&rft.au=MARTIN-LATRY,%20Karin&LATRY,%20P&PUCHEU,%20Y&COUFFINHAL,%20Thierry&rft.genre=article |
